{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-268948","form_type":"8-K","ticker":"CALC","cik":"0001534133","company_name":"CalciMedica, Inc.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.410376+00:00","generated_at":"2026-06-09T00:09:06.153900+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CalciMedica reports $14.6M cash; Auxora shows 53% hospital stay reduction in CRSPA cohort","bullets":["Preliminary cash, equivalents, and short-term investments of $14.6M as of Sept 30, 2023; expected to fund operations through Q3 2024.","Auxora (zegocractin) reduced average hospital stay from 13.4 to 6.3 days (53% reduction) in initial cohort of CRSPA study vs historical control.","No patients treated with Auxora required total parenteral nutrition (TPN) vs 68.8% in control.","Recommended dose established for children with ALL experiencing asparaginase-associated pancreatitis: dose level 1.","Data to be presented at ASH Meeting Dec 9-12, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-268948","json":"https://secwatch.observer/filing/0001193125-23-268948.json","markdown":"https://secwatch.observer/filing/0001193125-23-268948.md","text":"https://secwatch.observer/filing/0001193125-23-268948.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534133/000119312523268948/0001193125-23-268948-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534133/000119312523268948/d565256d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:09:06.153900+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}